The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
The U.S. Food and Drug Administration (FDA) has approved a new pain pill called Journavx, designed to mitigate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...
"There's different kinds of pain, just like we know in humans," explains Dr. Jerry Klein, a chief veterinary officer at the ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.